Owens & Minor, Inc. (NYSE:OMI) is a healthcare logistics company that provides supply chain services to healthcare providers and manufacturers. The company is set to release its quarterly earnings on February 28, 2025.
Wall Street estimates the earnings per share to be $0.53, with projected revenue of approximately $2.68 billion. According to Zacks Investment Research, OMI is expected to surpass these earnings estimates. Despite this optimism, the market anticipates a year-over-year decline in earnings, even though revenues are expected to be higher for the quarter ending December 2024.
This mixed outlook could influence the stock price significantly. OMI’s financial metrics reveal some challenges. The company has a negative price-to-earnings (P/E) ratio of -10.90, indicating current losses. The price-to-sales ratio is low at 0.05, suggesting the stock is valued at a fraction of its sales. These figures highlight the company’s current financial difficulties.
The enterprise value to sales ratio is 0.25, reflecting OMI’s valuation relative to its revenue. Additionally, the enterprise value to operating cash flow ratio is 13.15, providing insight into the company’s cash flow generation. The negative earnings yield of -9.17% further underscores the financial challenges OMI faces.
OMI’s debt-to-equity ratio stands at 2.48, indicating a higher level of debt compared to equity. However, the current ratio of 1.09 suggests that the company has slightly more current assets than current liabilities, offering some short-term financial stability. The upcoming earnings call will be crucial in assessing the sustainability of any immediate price changes and future earnings expectations.